Microbot Medical Wins First OBL Order for LIBERTY Robotic System

What happened

Microbot Medical received an order from California-based ELMNT IR for up to a 12-month supply of its LIBERTY Endovascular Robotic System. ELMNT IR is LIBERTY's first Office-Based Laboratory customer worldwide and Microbot's first West Coast customer.

Confirmed

Global impact / market context

This first order shows LIBERTY can win paying customers beyond hospitals, opening a new sales channel. If more office labs buy the system, Microbot could earn recurring revenue from supplies, which may support future growth and make the company less dependent on a single type of customer.

Analyst inference

Microbot expects office-based labs to be a growing market segment as more peripheral vascular procedures move to these settings. The customer highlighted the system's compact size, efficient workflow, and lack of upfront capital costs, which may make robotic programs easier for smaller labs to afford.

Analyst inference

What to watch

1. Watch whether ELMNT IR completes the full 12-month supply order and uses LIBERTY in routine procedures, since the order covers up to a year rather than a fixed commitment. Confirmed
2. Track whether Microbot announces more office-based lab customers, especially on the West Coast, which would show whether this first order leads to repeatable sales. Proposed
3. Monitor growth in peripheral vascular procedures at office-based labs, because Microbot expects rising procedure volumes there to create additional revenue opportunity for LIBERTY. Analyst inference

Evidence

• Original source link unavailable